Description
THERAPEUTIC APHERESIS
First action · last action
2024-02-28 · 2025-04-10
Transactions
3
First transaction's obligation
$46,419
Base + all options value (sum of deltas)
$48,500
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER)
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36C26024D0019
NAICS
621991 · BLOOD AND ORGAN BANKS
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2024-02-28+$46,419= $46,419
- Mod P000012024-06-04+$40,535= $86,954
- Mod P000022025-04-10-$38,454= $48,500
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2024-02-28 | +$46,419 | $46,419 | THERAPEUTIC APHERESIS |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-06-04 | +$40,535 | $86,954 | THERAPEUTIC APHERESIS |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2025-04-10 | −$38,454 | $48,500 | THERAPEUTIC APHERESIS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI G69LHXJ3ABL5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25226N0550 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $2,500 | FY2026 |
| 36C25226N0551 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $2,100 | FY2026 |
| 36C25226N0549 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $170 | FY2026 |
| 36C25226N0548 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $10,000 | FY2026 |
| 36C25026P0816 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $19,329 | FY2026 |
| 36C24126N0603 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $1,998,719 | FY2026 |
Other recipients under Q701 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26024N0355 | NW MONITORING LLC | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $30,000 | FY2024 |
| 36C26022P0033 | MOAB STERILIZATION STAFFING, INC | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $203,166 | FY2022 |
| 36C26022N0074 | A-TEAM SOLUTIONS LLC | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $10,433 | FY2022 |
| 36C26021P1066 | CAMEO CONSULTING GROUP LLC | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $16,567 | FY2021 |
| 36C26021P0736 | MOAB STERILIZATION STAFFING, INC | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $124,259 | FY2021 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26024N0162_3600_36C26024D0019_3600 · retrieved 2026-09-26.